{"id":"https://openalex.org/W2083135484","doi":"https://doi.org/10.1158/1078-0432.ccr-10-2918","title":"Prognostic and Predictive Role of Lactate Dehydrogenase 5 Expression in Colorectal Cancer Patients Treated with PTK787/ZK 222584 (Vatalanib) Antiangiogenic Therapy","display_name":"Prognostic and Predictive Role of Lactate Dehydrogenase 5 Expression in Colorectal Cancer Patients Treated with PTK787/ZK 222584 (Vatalanib) Antiangiogenic Therapy","alternate_titles":[],"publication_year":2011,"publication_date":"2011-07-15","ids":{"openalex":"https://openalex.org/W2083135484","doi":"https://doi.org/10.1158/1078-0432.ccr-10-2918","mag":"2083135484","pmid":"https://pubmed.ncbi.nlm.nih.gov/21632858","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3145151"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.ccr-10-2918","doi":"https://doi.org/10.1158/1078-0432.ccr-10-2918","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-10-2918","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2083135484"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3145151","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5026228151","display_name":"Michael Ioannis Koukourakis","orcid":"https://orcid.org/0000-0002-2324-699X","observed_orcids":["https://orcid.org/0000-0002-2324-699X"]},"institutions":[{"id":"https://openalex.org/I147962203","display_name":"Democritus University of Thrace","ror":"https://ror.org/03bfqnx40","country_code":"GR","type":"education","lineage":["https://openalex.org/I147962203"]},{"id":"https://openalex.org/I150569930","display_name":"Bayer (United States)","ror":"https://ror.org/034ffbg36","country_code":"US","type":"company","lineage":["https://openalex.org/I150569930","https://openalex.org/I67348948"]},{"id":"https://openalex.org/I2801316944","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I2801316944"]},{"id":"https://openalex.org/I2802742124","display_name":"John Radcliffe Hospital","ror":"https://ror.org/0080acb59","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802742124","https://openalex.org/I4210127145","https://openalex.org/I4210147381"]},{"id":"https://openalex.org/I4210143288","display_name":"Bayer (Finland)","ror":"https://ror.org/03cmx5943","country_code":"FI","type":"company","lineage":["https://openalex.org/I4210143288","https://openalex.org/I67348948"]},{"id":"https://openalex.org/I4210162051","display_name":"University Hospital Carl Gustav Carus","ror":"https://ror.org/04za5zm41","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210162051"]},{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE","FI","GB","GR","US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Michael I. Koukourakis","raw_affiliation_strings":["Authors' Affiliations:\u20081Departments of Pathology and Radiotherapy/Oncology, Democritus University of Thrace, Alexandroupolis, Greece; 2Cancer Research UK, Molecular Oncology Laboratories, Weatherall Institute of Molecular Medicine and Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, Oxford, United Kingdom; 3University of Essen, West German Cancer Center, Essen; 4University Hospital Dresden, Dresden, Germany; 5Novartis Pharmaceuticals Co., East Hanover; 6Bayer Healthcare Pharmaceuticals, New Jersey; 7Bayer Schering Pharma Oy, Espoo, Finland; and 8Bayer Healthcare Pharmaceuticals, Berlin, Germany","Bayer Healthcare Pharmaceuticals, Berlin, Germany","Bayer Healthcare Pharmaceuticals, New Jersey","Bayer Schering Pharma Oy, Espoo, Finland","Novartis Pharmaceuticals Co., East Hanover","University Hospital Dresden, Dresden, Germany","University of Essen, West German Cancer Center, Essen"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Departments of Pathology and Radiotherapy/Oncology, Democritus University of Thrace, Alexandroupolis, Greece; 2Cancer Research UK, Molecular Oncology Laboratories, Weatherall Institute of Molecular Medicine and Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, Oxford, United Kingdom; 3University of Essen, West German Cancer Center, Essen; 4University Hospital Dresden, Dresden, Germany; 5Novartis Pharmaceuticals Co., East Hanover; 6Bayer Healthcare Pharmaceuticals, New Jersey; 7Bayer Schering Pharma Oy, Espoo, Finland; and 8Bayer Healthcare Pharmaceuticals, Berlin, Germany","institution_ids":["https://openalex.org/I147962203","https://openalex.org/I2801316944","https://openalex.org/I2802742124"]},{"raw_affiliation_string":"Bayer Healthcare Pharmaceuticals, Berlin, Germany","institution_ids":["https://openalex.org/I67348948"]},{"raw_affiliation_string":"Bayer Healthcare Pharmaceuticals, New Jersey","institution_ids":["https://openalex.org/I150569930"]},{"raw_affiliation_string":"Bayer Schering Pharma Oy, Espoo, Finland","institution_ids":["https://openalex.org/I4210143288"]},{"raw_affiliation_string":"Novartis Pharmaceuticals Co., East Hanover","institution_ids":[]},{"raw_affiliation_string":"University Hospital Dresden, Dresden, Germany","institution_ids":["https://openalex.org/I4210162051"]},{"raw_affiliation_string":"University of Essen, West German Cancer Center, Essen","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026202643","display_name":"Alexandra N. Giatromanolaki","orcid":"https://orcid.org/0000-0003-3706-8845","observed_orcids":["https://orcid.org/0000-0003-3706-8845"]},"institutions":[{"id":"https://openalex.org/I147962203","display_name":"Democritus University of Thrace","ror":"https://ror.org/03bfqnx40","country_code":"GR","type":"education","lineage":["https://openalex.org/I147962203"]},{"id":"https://openalex.org/I150569930","display_name":"Bayer (United States)","ror":"https://ror.org/034ffbg36","country_code":"US","type":"company","lineage":["https://openalex.org/I150569930","https://openalex.org/I67348948"]},{"id":"https://openalex.org/I2801316944","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I2801316944"]},{"id":"https://openalex.org/I2802742124","display_name":"John Radcliffe Hospital","ror":"https://ror.org/0080acb59","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802742124","https://openalex.org/I4210127145","https://openalex.org/I4210147381"]},{"id":"https://openalex.org/I4210143288","display_name":"Bayer (Finland)","ror":"https://ror.org/03cmx5943","country_code":"FI","type":"company","lineage":["https://openalex.org/I4210143288","https://openalex.org/I67348948"]},{"id":"https://openalex.org/I4210162051","display_name":"University Hospital Carl Gustav Carus","ror":"https://ror.org/04za5zm41","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210162051"]},{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE","FI","GB","GR","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Alexandra Giatromanolaki","raw_affiliation_strings":["Authors' Affiliations:\u20081Departments of Pathology and Radiotherapy/Oncology, Democritus University of Thrace, Alexandroupolis, Greece; 2Cancer Research UK, Molecular Oncology Laboratories, Weatherall Institute of Molecular Medicine and Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, Oxford, United Kingdom; 3University of Essen, West German Cancer Center, Essen; 4University Hospital Dresden, Dresden, Germany; 5Novartis Pharmaceuticals Co., East Hanover; 6Bayer Healthcare Pharmaceuticals, New Jersey; 7Bayer Schering Pharma Oy, Espoo, Finland; and 8Bayer Healthcare Pharmaceuticals, Berlin, Germany","Bayer Healthcare Pharmaceuticals, Berlin, Germany","Bayer Healthcare Pharmaceuticals, New Jersey","Bayer Schering Pharma Oy, Espoo, Finland","Novartis Pharmaceuticals Co., East Hanover","University Hospital Dresden, Dresden, Germany","University of Essen, West German Cancer Center, Essen"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Departments of Pathology and Radiotherapy/Oncology, Democritus University of Thrace, Alexandroupolis, Greece; 2Cancer Research UK, Molecular Oncology Laboratories, Weatherall Institute of Molecular Medicine and Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, Oxford, United Kingdom; 3University of Essen, West German Cancer Center, Essen; 4University Hospital Dresden, Dresden, Germany; 5Novartis Pharmaceuticals Co., East Hanover; 6Bayer Healthcare Pharmaceuticals, New Jersey; 7Bayer Schering Pharma Oy, Espoo, Finland; and 8Bayer Healthcare Pharmaceuticals, Berlin, Germany","institution_ids":["https://openalex.org/I147962203","https://openalex.org/I2801316944","https://openalex.org/I2802742124"]},{"raw_affiliation_string":"Bayer Healthcare Pharmaceuticals, Berlin, Germany","institution_ids":["https://openalex.org/I67348948"]},{"raw_affiliation_string":"Bayer Healthcare Pharmaceuticals, New Jersey","institution_ids":["https://openalex.org/I150569930"]},{"raw_affiliation_string":"Bayer Schering Pharma Oy, Espoo, Finland","institution_ids":["https://openalex.org/I4210143288"]},{"raw_affiliation_string":"Novartis Pharmaceuticals Co., East Hanover","institution_ids":[]},{"raw_affiliation_string":"University Hospital Dresden, Dresden, Germany","institution_ids":["https://openalex.org/I4210162051"]},{"raw_affiliation_string":"University of Essen, West German Cancer Center, Essen","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033275045","display_name":"Efthimios Sivridis","orcid":"https://orcid.org/0000-0002-2802-1386","observed_orcids":["https://orcid.org/0000-0002-2802-1386"]},"institutions":[{"id":"https://openalex.org/I147962203","display_name":"Democritus University of Thrace","ror":"https://ror.org/03bfqnx40","country_code":"GR","type":"education","lineage":["https://openalex.org/I147962203"]},{"id":"https://openalex.org/I150569930","display_name":"Bayer (United States)","ror":"https://ror.org/034ffbg36","country_code":"US","type":"company","lineage":["https://openalex.org/I150569930","https://openalex.org/I67348948"]},{"id":"https://openalex.org/I2801316944","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I2801316944"]},{"id":"https://openalex.org/I2802742124","display_name":"John Radcliffe Hospital","ror":"https://ror.org/0080acb59","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802742124","https://openalex.org/I4210127145","https://openalex.org/I4210147381"]},{"id":"https://openalex.org/I4210143288","display_name":"Bayer (Finland)","ror":"https://ror.org/03cmx5943","country_code":"FI","type":"company","lineage":["https://openalex.org/I4210143288","https://openalex.org/I67348948"]},{"id":"https://openalex.org/I4210162051","display_name":"University Hospital Carl Gustav Carus","ror":"https://ror.org/04za5zm41","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210162051"]},{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE","FI","GB","GR","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Efthimios Sivridis","raw_affiliation_strings":["Authors' Affiliations:\u20081Departments of Pathology and Radiotherapy/Oncology, Democritus University of Thrace, Alexandroupolis, Greece; 2Cancer Research UK, Molecular Oncology Laboratories, Weatherall Institute of Molecular Medicine and Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, Oxford, United Kingdom; 3University of Essen, West German Cancer Center, Essen; 4University Hospital Dresden, Dresden, Germany; 5Novartis Pharmaceuticals Co., East Hanover; 6Bayer Healthcare Pharmaceuticals, New Jersey; 7Bayer Schering Pharma Oy, Espoo, Finland; and 8Bayer Healthcare Pharmaceuticals, Berlin, Germany","Bayer Healthcare Pharmaceuticals, Berlin, Germany","Bayer Healthcare Pharmaceuticals, New Jersey","Bayer Schering Pharma Oy, Espoo, Finland","Novartis Pharmaceuticals Co., East Hanover","University Hospital Dresden, Dresden, Germany","University of Essen, West German Cancer Center, Essen"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Departments of Pathology and Radiotherapy/Oncology, Democritus University of Thrace, Alexandroupolis, Greece; 2Cancer Research UK, Molecular Oncology Laboratories, Weatherall Institute of Molecular Medicine and Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, Oxford, United Kingdom; 3University of Essen, West German Cancer Center, Essen; 4University Hospital Dresden, Dresden, Germany; 5Novartis Pharmaceuticals Co., East Hanover; 6Bayer Healthcare Pharmaceuticals, New Jersey; 7Bayer Schering Pharma Oy, Espoo, Finland; and 8Bayer Healthcare Pharmaceuticals, Berlin, Germany","institution_ids":["https://openalex.org/I147962203","https://openalex.org/I2801316944","https://openalex.org/I2802742124"]},{"raw_affiliation_string":"Bayer Healthcare Pharmaceuticals, Berlin, Germany","institution_ids":["https://openalex.org/I67348948"]},{"raw_affiliation_string":"Bayer Healthcare Pharmaceuticals, New Jersey","institution_ids":["https://openalex.org/I150569930"]},{"raw_affiliation_string":"Bayer Schering Pharma Oy, Espoo, Finland","institution_ids":["https://openalex.org/I4210143288"]},{"raw_affiliation_string":"Novartis Pharmaceuticals Co., East Hanover","institution_ids":[]},{"raw_affiliation_string":"University Hospital Dresden, Dresden, Germany","institution_ids":["https://openalex.org/I4210162051"]},{"raw_affiliation_string":"University of Essen, West German Cancer Center, Essen","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108427843","display_name":"Kevin C. Gatter","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I147962203","display_name":"Democritus University of Thrace","ror":"https://ror.org/03bfqnx40","country_code":"GR","type":"education","lineage":["https://openalex.org/I147962203"]},{"id":"https://openalex.org/I150569930","display_name":"Bayer (United States)","ror":"https://ror.org/034ffbg36","country_code":"US","type":"company","lineage":["https://openalex.org/I150569930","https://openalex.org/I67348948"]},{"id":"https://openalex.org/I2801316944","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I2801316944"]},{"id":"https://openalex.org/I2802742124","display_name":"John Radcliffe Hospital","ror":"https://ror.org/0080acb59","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802742124","https://openalex.org/I4210127145","https://openalex.org/I4210147381"]},{"id":"https://openalex.org/I4210143288","display_name":"Bayer (Finland)","ror":"https://ror.org/03cmx5943","country_code":"FI","type":"company","lineage":["https://openalex.org/I4210143288","https://openalex.org/I67348948"]},{"id":"https://openalex.org/I4210162051","display_name":"University Hospital Carl Gustav Carus","ror":"https://ror.org/04za5zm41","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210162051"]},{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE","FI","GB","GR","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kevin C. Gatter","raw_affiliation_strings":["Authors' Affiliations:\u20081Departments of Pathology and Radiotherapy/Oncology, Democritus University of Thrace, Alexandroupolis, Greece; 2Cancer Research UK, Molecular Oncology Laboratories, Weatherall Institute of Molecular Medicine and Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, Oxford, United Kingdom; 3University of Essen, West German Cancer Center, Essen; 4University Hospital Dresden, Dresden, Germany; 5Novartis Pharmaceuticals Co., East Hanover; 6Bayer Healthcare Pharmaceuticals, New Jersey; 7Bayer Schering Pharma Oy, Espoo, Finland; and 8Bayer Healthcare Pharmaceuticals, Berlin, Germany","Bayer Healthcare Pharmaceuticals, Berlin, Germany","Bayer Healthcare Pharmaceuticals, New Jersey","Bayer Schering Pharma Oy, Espoo, Finland","Novartis Pharmaceuticals Co., East Hanover","University Hospital Dresden, Dresden, Germany","University of Essen, West German Cancer Center, Essen"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Departments of Pathology and Radiotherapy/Oncology, Democritus University of Thrace, Alexandroupolis, Greece; 2Cancer Research UK, Molecular Oncology Laboratories, Weatherall Institute of Molecular Medicine and Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, Oxford, United Kingdom; 3University of Essen, West German Cancer Center, Essen; 4University Hospital Dresden, Dresden, Germany; 5Novartis Pharmaceuticals Co., East Hanover; 6Bayer Healthcare Pharmaceuticals, New Jersey; 7Bayer Schering Pharma Oy, Espoo, Finland; and 8Bayer Healthcare Pharmaceuticals, Berlin, Germany","institution_ids":["https://openalex.org/I147962203","https://openalex.org/I2801316944","https://openalex.org/I2802742124"]},{"raw_affiliation_string":"Bayer Healthcare Pharmaceuticals, Berlin, Germany","institution_ids":["https://openalex.org/I67348948"]},{"raw_affiliation_string":"Bayer Healthcare Pharmaceuticals, New Jersey","institution_ids":["https://openalex.org/I150569930"]},{"raw_affiliation_string":"Bayer Schering Pharma Oy, Espoo, Finland","institution_ids":["https://openalex.org/I4210143288"]},{"raw_affiliation_string":"Novartis Pharmaceuticals Co., East Hanover","institution_ids":[]},{"raw_affiliation_string":"University Hospital Dresden, Dresden, Germany","institution_ids":["https://openalex.org/I4210162051"]},{"raw_affiliation_string":"University of Essen, West German Cancer Center, Essen","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039743409","display_name":"Tanja Trarbach","orcid":"https://orcid.org/0000-0002-1275-4040","observed_orcids":["https://orcid.org/0000-0002-1275-4040"]},"institutions":[{"id":"https://openalex.org/I147962203","display_name":"Democritus University of Thrace","ror":"https://ror.org/03bfqnx40","country_code":"GR","type":"education","lineage":["https://openalex.org/I147962203"]},{"id":"https://openalex.org/I150569930","display_name":"Bayer (United States)","ror":"https://ror.org/034ffbg36","country_code":"US","type":"company","lineage":["https://openalex.org/I150569930","https://openalex.org/I67348948"]},{"id":"https://openalex.org/I2801316944","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I2801316944"]},{"id":"https://openalex.org/I2802742124","display_name":"John Radcliffe Hospital","ror":"https://ror.org/0080acb59","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802742124","https://openalex.org/I4210127145","https://openalex.org/I4210147381"]},{"id":"https://openalex.org/I4210143288","display_name":"Bayer (Finland)","ror":"https://ror.org/03cmx5943","country_code":"FI","type":"company","lineage":["https://openalex.org/I4210143288","https://openalex.org/I67348948"]},{"id":"https://openalex.org/I4210162051","display_name":"University Hospital Carl Gustav Carus","ror":"https://ror.org/04za5zm41","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210162051"]},{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE","FI","GB","GR","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Tanja Trarbach","raw_affiliation_strings":["Authors' Affiliations:\u20081Departments of Pathology and Radiotherapy/Oncology, Democritus University of Thrace, Alexandroupolis, Greece; 2Cancer Research UK, Molecular Oncology Laboratories, Weatherall Institute of Molecular Medicine and Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, Oxford, United Kingdom; 3University of Essen, West German Cancer Center, Essen; 4University Hospital Dresden, Dresden, Germany; 5Novartis Pharmaceuticals Co., East Hanover; 6Bayer Healthcare Pharmaceuticals, New Jersey; 7Bayer Schering Pharma Oy, Espoo, Finland; and 8Bayer Healthcare Pharmaceuticals, Berlin, Germany","Bayer Healthcare Pharmaceuticals, Berlin, Germany","Bayer Healthcare Pharmaceuticals, New Jersey","Bayer Schering Pharma Oy, Espoo, Finland","Novartis Pharmaceuticals Co., East Hanover","University Hospital Dresden, Dresden, Germany","University of Essen, West German Cancer Center, Essen"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Departments of Pathology and Radiotherapy/Oncology, Democritus University of Thrace, Alexandroupolis, Greece; 2Cancer Research UK, Molecular Oncology Laboratories, Weatherall Institute of Molecular Medicine and Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, Oxford, United Kingdom; 3University of Essen, West German Cancer Center, Essen; 4University Hospital Dresden, Dresden, Germany; 5Novartis Pharmaceuticals Co., East Hanover; 6Bayer Healthcare Pharmaceuticals, New Jersey; 7Bayer Schering Pharma Oy, Espoo, Finland; and 8Bayer Healthcare Pharmaceuticals, Berlin, Germany","institution_ids":["https://openalex.org/I147962203","https://openalex.org/I2801316944","https://openalex.org/I2802742124"]},{"raw_affiliation_string":"Bayer Healthcare Pharmaceuticals, Berlin, Germany","institution_ids":["https://openalex.org/I67348948"]},{"raw_affiliation_string":"Bayer Healthcare Pharmaceuticals, New Jersey","institution_ids":["https://openalex.org/I150569930"]},{"raw_affiliation_string":"Bayer Schering Pharma Oy, Espoo, Finland","institution_ids":["https://openalex.org/I4210143288"]},{"raw_affiliation_string":"Novartis Pharmaceuticals Co., East Hanover","institution_ids":[]},{"raw_affiliation_string":"University Hospital Dresden, Dresden, Germany","institution_ids":["https://openalex.org/I4210162051"]},{"raw_affiliation_string":"University of Essen, West German Cancer Center, Essen","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019710731","display_name":"Gunnar Folprecht","orcid":"https://orcid.org/0000-0002-9321-9911","observed_orcids":["https://orcid.org/0000-0002-9321-9911"]},"institutions":[{"id":"https://openalex.org/I147962203","display_name":"Democritus University of Thrace","ror":"https://ror.org/03bfqnx40","country_code":"GR","type":"education","lineage":["https://openalex.org/I147962203"]},{"id":"https://openalex.org/I150569930","display_name":"Bayer (United States)","ror":"https://ror.org/034ffbg36","country_code":"US","type":"company","lineage":["https://openalex.org/I150569930","https://openalex.org/I67348948"]},{"id":"https://openalex.org/I2801316944","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I2801316944"]},{"id":"https://openalex.org/I2802742124","display_name":"John Radcliffe Hospital","ror":"https://ror.org/0080acb59","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802742124","https://openalex.org/I4210127145","https://openalex.org/I4210147381"]},{"id":"https://openalex.org/I4210143288","display_name":"Bayer (Finland)","ror":"https://ror.org/03cmx5943","country_code":"FI","type":"company","lineage":["https://openalex.org/I4210143288","https://openalex.org/I67348948"]},{"id":"https://openalex.org/I4210162051","display_name":"University Hospital Carl Gustav Carus","ror":"https://ror.org/04za5zm41","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210162051"]},{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE","FI","GB","GR","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Gunnar Folprecht","raw_affiliation_strings":["Authors' Affiliations:\u20081Departments of Pathology and Radiotherapy/Oncology, Democritus University of Thrace, Alexandroupolis, Greece; 2Cancer Research UK, Molecular Oncology Laboratories, Weatherall Institute of Molecular Medicine and Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, Oxford, United Kingdom; 3University of Essen, West German Cancer Center, Essen; 4University Hospital Dresden, Dresden, Germany; 5Novartis Pharmaceuticals Co., East Hanover; 6Bayer Healthcare Pharmaceuticals, New Jersey; 7Bayer Schering Pharma Oy, Espoo, Finland; and 8Bayer Healthcare Pharmaceuticals, Berlin, Germany","Bayer Healthcare Pharmaceuticals, Berlin, Germany","Bayer Healthcare Pharmaceuticals, New Jersey","Bayer Schering Pharma Oy, Espoo, Finland","Novartis Pharmaceuticals Co., East Hanover","University Hospital Dresden, Dresden, Germany","University of Essen, West German Cancer Center, Essen"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Departments of Pathology and Radiotherapy/Oncology, Democritus University of Thrace, Alexandroupolis, Greece; 2Cancer Research UK, Molecular Oncology Laboratories, Weatherall Institute of Molecular Medicine and Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, Oxford, United Kingdom; 3University of Essen, West German Cancer Center, Essen; 4University Hospital Dresden, Dresden, Germany; 5Novartis Pharmaceuticals Co., East Hanover; 6Bayer Healthcare Pharmaceuticals, New Jersey; 7Bayer Schering Pharma Oy, Espoo, Finland; and 8Bayer Healthcare Pharmaceuticals, Berlin, Germany","institution_ids":["https://openalex.org/I147962203","https://openalex.org/I2801316944","https://openalex.org/I2802742124"]},{"raw_affiliation_string":"Bayer Healthcare Pharmaceuticals, Berlin, Germany","institution_ids":["https://openalex.org/I67348948"]},{"raw_affiliation_string":"Bayer Healthcare Pharmaceuticals, New Jersey","institution_ids":["https://openalex.org/I150569930"]},{"raw_affiliation_string":"Bayer Schering Pharma Oy, Espoo, Finland","institution_ids":["https://openalex.org/I4210143288"]},{"raw_affiliation_string":"Novartis Pharmaceuticals Co., East Hanover","institution_ids":[]},{"raw_affiliation_string":"University Hospital Dresden, Dresden, Germany","institution_ids":["https://openalex.org/I4210162051"]},{"raw_affiliation_string":"University of Essen, West German Cancer Center, Essen","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113700678","display_name":"Michael M. Shi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I147962203","display_name":"Democritus University of Thrace","ror":"https://ror.org/03bfqnx40","country_code":"GR","type":"education","lineage":["https://openalex.org/I147962203"]},{"id":"https://openalex.org/I150569930","display_name":"Bayer (United States)","ror":"https://ror.org/034ffbg36","country_code":"US","type":"company","lineage":["https://openalex.org/I150569930","https://openalex.org/I67348948"]},{"id":"https://openalex.org/I2801316944","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I2801316944"]},{"id":"https://openalex.org/I2802742124","display_name":"John Radcliffe Hospital","ror":"https://ror.org/0080acb59","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802742124","https://openalex.org/I4210127145","https://openalex.org/I4210147381"]},{"id":"https://openalex.org/I4210143288","display_name":"Bayer (Finland)","ror":"https://ror.org/03cmx5943","country_code":"FI","type":"company","lineage":["https://openalex.org/I4210143288","https://openalex.org/I67348948"]},{"id":"https://openalex.org/I4210162051","display_name":"University Hospital Carl Gustav Carus","ror":"https://ror.org/04za5zm41","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210162051"]},{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE","FI","GB","GR","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Michael M. Shi","raw_affiliation_strings":["Authors' Affiliations:\u20081Departments of Pathology and Radiotherapy/Oncology, Democritus University of Thrace, Alexandroupolis, Greece; 2Cancer Research UK, Molecular Oncology Laboratories, Weatherall Institute of Molecular Medicine and Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, Oxford, United Kingdom; 3University of Essen, West German Cancer Center, Essen; 4University Hospital Dresden, Dresden, Germany; 5Novartis Pharmaceuticals Co., East Hanover; 6Bayer Healthcare Pharmaceuticals, New Jersey; 7Bayer Schering Pharma Oy, Espoo, Finland; and 8Bayer Healthcare Pharmaceuticals, Berlin, Germany","Bayer Healthcare Pharmaceuticals, Berlin, Germany","Bayer Healthcare Pharmaceuticals, New Jersey","Bayer Schering Pharma Oy, Espoo, Finland","Novartis Pharmaceuticals Co., East Hanover","University Hospital Dresden, Dresden, Germany","University of Essen, West German Cancer Center, Essen"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Departments of Pathology and Radiotherapy/Oncology, Democritus University of Thrace, Alexandroupolis, Greece; 2Cancer Research UK, Molecular Oncology Laboratories, Weatherall Institute of Molecular Medicine and Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, Oxford, United Kingdom; 3University of Essen, West German Cancer Center, Essen; 4University Hospital Dresden, Dresden, Germany; 5Novartis Pharmaceuticals Co., East Hanover; 6Bayer Healthcare Pharmaceuticals, New Jersey; 7Bayer Schering Pharma Oy, Espoo, Finland; and 8Bayer Healthcare Pharmaceuticals, Berlin, Germany","institution_ids":["https://openalex.org/I147962203","https://openalex.org/I2801316944","https://openalex.org/I2802742124"]},{"raw_affiliation_string":"Bayer Healthcare Pharmaceuticals, Berlin, Germany","institution_ids":["https://openalex.org/I67348948"]},{"raw_affiliation_string":"Bayer Healthcare Pharmaceuticals, New Jersey","institution_ids":["https://openalex.org/I150569930"]},{"raw_affiliation_string":"Bayer Schering Pharma Oy, Espoo, Finland","institution_ids":["https://openalex.org/I4210143288"]},{"raw_affiliation_string":"Novartis Pharmaceuticals Co., East Hanover","institution_ids":[]},{"raw_affiliation_string":"University Hospital Dresden, Dresden, Germany","institution_ids":["https://openalex.org/I4210162051"]},{"raw_affiliation_string":"University of Essen, West German Cancer Center, Essen","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062128184","display_name":"David Lebwohl","orcid":"https://orcid.org/0000-0002-4578-1977","observed_orcids":["https://orcid.org/0000-0002-4578-1977"]},"institutions":[{"id":"https://openalex.org/I147962203","display_name":"Democritus University of Thrace","ror":"https://ror.org/03bfqnx40","country_code":"GR","type":"education","lineage":["https://openalex.org/I147962203"]},{"id":"https://openalex.org/I150569930","display_name":"Bayer (United States)","ror":"https://ror.org/034ffbg36","country_code":"US","type":"company","lineage":["https://openalex.org/I150569930","https://openalex.org/I67348948"]},{"id":"https://openalex.org/I2801316944","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I2801316944"]},{"id":"https://openalex.org/I2802742124","display_name":"John Radcliffe Hospital","ror":"https://ror.org/0080acb59","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802742124","https://openalex.org/I4210127145","https://openalex.org/I4210147381"]},{"id":"https://openalex.org/I4210143288","display_name":"Bayer (Finland)","ror":"https://ror.org/03cmx5943","country_code":"FI","type":"company","lineage":["https://openalex.org/I4210143288","https://openalex.org/I67348948"]},{"id":"https://openalex.org/I4210162051","display_name":"University Hospital Carl Gustav Carus","ror":"https://ror.org/04za5zm41","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210162051"]},{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE","FI","GB","GR","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"David Lebwohl","raw_affiliation_strings":["Authors' Affiliations:\u20081Departments of Pathology and Radiotherapy/Oncology, Democritus University of Thrace, Alexandroupolis, Greece; 2Cancer Research UK, Molecular Oncology Laboratories, Weatherall Institute of Molecular Medicine and Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, Oxford, United Kingdom; 3University of Essen, West German Cancer Center, Essen; 4University Hospital Dresden, Dresden, Germany; 5Novartis Pharmaceuticals Co., East Hanover; 6Bayer Healthcare Pharmaceuticals, New Jersey; 7Bayer Schering Pharma Oy, Espoo, Finland; and 8Bayer Healthcare Pharmaceuticals, Berlin, Germany","Bayer Healthcare Pharmaceuticals, Berlin, Germany","Bayer Healthcare Pharmaceuticals, New Jersey","Bayer Schering Pharma Oy, Espoo, Finland","Novartis Pharmaceuticals Co., East Hanover","University Hospital Dresden, Dresden, Germany","University of Essen, West German Cancer Center, Essen"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Departments of Pathology and Radiotherapy/Oncology, Democritus University of Thrace, Alexandroupolis, Greece; 2Cancer Research UK, Molecular Oncology Laboratories, Weatherall Institute of Molecular Medicine and Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, Oxford, United Kingdom; 3University of Essen, West German Cancer Center, Essen; 4University Hospital Dresden, Dresden, Germany; 5Novartis Pharmaceuticals Co., East Hanover; 6Bayer Healthcare Pharmaceuticals, New Jersey; 7Bayer Schering Pharma Oy, Espoo, Finland; and 8Bayer Healthcare Pharmaceuticals, Berlin, Germany","institution_ids":["https://openalex.org/I147962203","https://openalex.org/I2801316944","https://openalex.org/I2802742124"]},{"raw_affiliation_string":"Bayer Healthcare Pharmaceuticals, Berlin, Germany","institution_ids":["https://openalex.org/I67348948"]},{"raw_affiliation_string":"Bayer Healthcare Pharmaceuticals, New Jersey","institution_ids":["https://openalex.org/I150569930"]},{"raw_affiliation_string":"Bayer Schering Pharma Oy, Espoo, Finland","institution_ids":["https://openalex.org/I4210143288"]},{"raw_affiliation_string":"Novartis Pharmaceuticals Co., East Hanover","institution_ids":[]},{"raw_affiliation_string":"University Hospital Dresden, Dresden, Germany","institution_ids":["https://openalex.org/I4210162051"]},{"raw_affiliation_string":"University of Essen, West German Cancer Center, Essen","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108523526","display_name":"Tarja Jalava","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I147962203","display_name":"Democritus University of Thrace","ror":"https://ror.org/03bfqnx40","country_code":"GR","type":"education","lineage":["https://openalex.org/I147962203"]},{"id":"https://openalex.org/I150569930","display_name":"Bayer (United States)","ror":"https://ror.org/034ffbg36","country_code":"US","type":"company","lineage":["https://openalex.org/I150569930","https://openalex.org/I67348948"]},{"id":"https://openalex.org/I2801316944","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I2801316944"]},{"id":"https://openalex.org/I2802742124","display_name":"John Radcliffe Hospital","ror":"https://ror.org/0080acb59","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802742124","https://openalex.org/I4210127145","https://openalex.org/I4210147381"]},{"id":"https://openalex.org/I4210143288","display_name":"Bayer (Finland)","ror":"https://ror.org/03cmx5943","country_code":"FI","type":"company","lineage":["https://openalex.org/I4210143288","https://openalex.org/I67348948"]},{"id":"https://openalex.org/I4210162051","display_name":"University Hospital Carl Gustav Carus","ror":"https://ror.org/04za5zm41","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210162051"]},{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE","FI","GB","GR","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Tarja Jalava","raw_affiliation_strings":["Authors' Affiliations:\u20081Departments of Pathology and Radiotherapy/Oncology, Democritus University of Thrace, Alexandroupolis, Greece; 2Cancer Research UK, Molecular Oncology Laboratories, Weatherall Institute of Molecular Medicine and Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, Oxford, United Kingdom; 3University of Essen, West German Cancer Center, Essen; 4University Hospital Dresden, Dresden, Germany; 5Novartis Pharmaceuticals Co., East Hanover; 6Bayer Healthcare Pharmaceuticals, New Jersey; 7Bayer Schering Pharma Oy, Espoo, Finland; and 8Bayer Healthcare Pharmaceuticals, Berlin, Germany","Bayer Healthcare Pharmaceuticals, Berlin, Germany","Bayer Healthcare Pharmaceuticals, New Jersey","Bayer Schering Pharma Oy, Espoo, Finland","Novartis Pharmaceuticals Co., East Hanover","University Hospital Dresden, Dresden, Germany","University of Essen, West German Cancer Center, Essen"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Departments of Pathology and Radiotherapy/Oncology, Democritus University of Thrace, Alexandroupolis, Greece; 2Cancer Research UK, Molecular Oncology Laboratories, Weatherall Institute of Molecular Medicine and Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, Oxford, United Kingdom; 3University of Essen, West German Cancer Center, Essen; 4University Hospital Dresden, Dresden, Germany; 5Novartis Pharmaceuticals Co., East Hanover; 6Bayer Healthcare Pharmaceuticals, New Jersey; 7Bayer Schering Pharma Oy, Espoo, Finland; and 8Bayer Healthcare Pharmaceuticals, Berlin, Germany","institution_ids":["https://openalex.org/I147962203","https://openalex.org/I2801316944","https://openalex.org/I2802742124"]},{"raw_affiliation_string":"Bayer Healthcare Pharmaceuticals, Berlin, Germany","institution_ids":["https://openalex.org/I67348948"]},{"raw_affiliation_string":"Bayer Healthcare Pharmaceuticals, New Jersey","institution_ids":["https://openalex.org/I150569930"]},{"raw_affiliation_string":"Bayer Schering Pharma Oy, Espoo, Finland","institution_ids":["https://openalex.org/I4210143288"]},{"raw_affiliation_string":"Novartis Pharmaceuticals Co., East Hanover","institution_ids":[]},{"raw_affiliation_string":"University Hospital Dresden, Dresden, Germany","institution_ids":["https://openalex.org/I4210162051"]},{"raw_affiliation_string":"University of Essen, West German Cancer Center, Essen","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068520667","display_name":"Dirk Laurent","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I147962203","display_name":"Democritus University of Thrace","ror":"https://ror.org/03bfqnx40","country_code":"GR","type":"education","lineage":["https://openalex.org/I147962203"]},{"id":"https://openalex.org/I150569930","display_name":"Bayer (United States)","ror":"https://ror.org/034ffbg36","country_code":"US","type":"company","lineage":["https://openalex.org/I150569930","https://openalex.org/I67348948"]},{"id":"https://openalex.org/I2801316944","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I2801316944"]},{"id":"https://openalex.org/I2802742124","display_name":"John Radcliffe Hospital","ror":"https://ror.org/0080acb59","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802742124","https://openalex.org/I4210127145","https://openalex.org/I4210147381"]},{"id":"https://openalex.org/I4210143288","display_name":"Bayer (Finland)","ror":"https://ror.org/03cmx5943","country_code":"FI","type":"company","lineage":["https://openalex.org/I4210143288","https://openalex.org/I67348948"]},{"id":"https://openalex.org/I4210162051","display_name":"University Hospital Carl Gustav Carus","ror":"https://ror.org/04za5zm41","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210162051"]},{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE","FI","GB","GR","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Dirk Laurent","raw_affiliation_strings":["Authors' Affiliations:\u20081Departments of Pathology and Radiotherapy/Oncology, Democritus University of Thrace, Alexandroupolis, Greece; 2Cancer Research UK, Molecular Oncology Laboratories, Weatherall Institute of Molecular Medicine and Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, Oxford, United Kingdom; 3University of Essen, West German Cancer Center, Essen; 4University Hospital Dresden, Dresden, Germany; 5Novartis Pharmaceuticals Co., East Hanover; 6Bayer Healthcare Pharmaceuticals, New Jersey; 7Bayer Schering Pharma Oy, Espoo, Finland; and 8Bayer Healthcare Pharmaceuticals, Berlin, Germany","Bayer Healthcare Pharmaceuticals, Berlin, Germany","Bayer Healthcare Pharmaceuticals, New Jersey","Bayer Schering Pharma Oy, Espoo, Finland","Novartis Pharmaceuticals Co., East Hanover","University Hospital Dresden, Dresden, Germany","University of Essen, West German Cancer Center, Essen"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Departments of Pathology and Radiotherapy/Oncology, Democritus University of Thrace, Alexandroupolis, Greece; 2Cancer Research UK, Molecular Oncology Laboratories, Weatherall Institute of Molecular Medicine and Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, Oxford, United Kingdom; 3University of Essen, West German Cancer Center, Essen; 4University Hospital Dresden, Dresden, Germany; 5Novartis Pharmaceuticals Co., East Hanover; 6Bayer Healthcare Pharmaceuticals, New Jersey; 7Bayer Schering Pharma Oy, Espoo, Finland; and 8Bayer Healthcare Pharmaceuticals, Berlin, Germany","institution_ids":["https://openalex.org/I147962203","https://openalex.org/I2801316944","https://openalex.org/I2802742124"]},{"raw_affiliation_string":"Bayer Healthcare Pharmaceuticals, Berlin, Germany","institution_ids":["https://openalex.org/I67348948"]},{"raw_affiliation_string":"Bayer Healthcare Pharmaceuticals, New Jersey","institution_ids":["https://openalex.org/I150569930"]},{"raw_affiliation_string":"Bayer Schering Pharma Oy, Espoo, Finland","institution_ids":["https://openalex.org/I4210143288"]},{"raw_affiliation_string":"Novartis Pharmaceuticals Co., East Hanover","institution_ids":[]},{"raw_affiliation_string":"University Hospital Dresden, Dresden, Germany","institution_ids":["https://openalex.org/I4210162051"]},{"raw_affiliation_string":"University of Essen, West German Cancer Center, Essen","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110576594","display_name":"Gerold Meinhardt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I147962203","display_name":"Democritus University of Thrace","ror":"https://ror.org/03bfqnx40","country_code":"GR","type":"education","lineage":["https://openalex.org/I147962203"]},{"id":"https://openalex.org/I150569930","display_name":"Bayer (United States)","ror":"https://ror.org/034ffbg36","country_code":"US","type":"company","lineage":["https://openalex.org/I150569930","https://openalex.org/I67348948"]},{"id":"https://openalex.org/I2801316944","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I2801316944"]},{"id":"https://openalex.org/I2802742124","display_name":"John Radcliffe Hospital","ror":"https://ror.org/0080acb59","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802742124","https://openalex.org/I4210127145","https://openalex.org/I4210147381"]},{"id":"https://openalex.org/I4210143288","display_name":"Bayer (Finland)","ror":"https://ror.org/03cmx5943","country_code":"FI","type":"company","lineage":["https://openalex.org/I4210143288","https://openalex.org/I67348948"]},{"id":"https://openalex.org/I4210162051","display_name":"University Hospital Carl Gustav Carus","ror":"https://ror.org/04za5zm41","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210162051"]},{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE","FI","GB","GR","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Gerold Meinhardt","raw_affiliation_strings":["Authors' Affiliations:\u20081Departments of Pathology and Radiotherapy/Oncology, Democritus University of Thrace, Alexandroupolis, Greece; 2Cancer Research UK, Molecular Oncology Laboratories, Weatherall Institute of Molecular Medicine and Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, Oxford, United Kingdom; 3University of Essen, West German Cancer Center, Essen; 4University Hospital Dresden, Dresden, Germany; 5Novartis Pharmaceuticals Co., East Hanover; 6Bayer Healthcare Pharmaceuticals, New Jersey; 7Bayer Schering Pharma Oy, Espoo, Finland; and 8Bayer Healthcare Pharmaceuticals, Berlin, Germany","Bayer Healthcare Pharmaceuticals, Berlin, Germany","Bayer Healthcare Pharmaceuticals, New Jersey","Bayer Schering Pharma Oy, Espoo, Finland","Novartis Pharmaceuticals Co., East Hanover","University Hospital Dresden, Dresden, Germany","University of Essen, West German Cancer Center, Essen"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Departments of Pathology and Radiotherapy/Oncology, Democritus University of Thrace, Alexandroupolis, Greece; 2Cancer Research UK, Molecular Oncology Laboratories, Weatherall Institute of Molecular Medicine and Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, Oxford, United Kingdom; 3University of Essen, West German Cancer Center, Essen; 4University Hospital Dresden, Dresden, Germany; 5Novartis Pharmaceuticals Co., East Hanover; 6Bayer Healthcare Pharmaceuticals, New Jersey; 7Bayer Schering Pharma Oy, Espoo, Finland; and 8Bayer Healthcare Pharmaceuticals, Berlin, Germany","institution_ids":["https://openalex.org/I147962203","https://openalex.org/I2801316944","https://openalex.org/I2802742124"]},{"raw_affiliation_string":"Bayer Healthcare Pharmaceuticals, Berlin, Germany","institution_ids":["https://openalex.org/I67348948"]},{"raw_affiliation_string":"Bayer Healthcare Pharmaceuticals, New Jersey","institution_ids":["https://openalex.org/I150569930"]},{"raw_affiliation_string":"Bayer Schering Pharma Oy, Espoo, Finland","institution_ids":["https://openalex.org/I4210143288"]},{"raw_affiliation_string":"Novartis Pharmaceuticals Co., East Hanover","institution_ids":[]},{"raw_affiliation_string":"University Hospital Dresden, Dresden, Germany","institution_ids":["https://openalex.org/I4210162051"]},{"raw_affiliation_string":"University of Essen, West German Cancer Center, Essen","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5079633934","display_name":"Adrian Llewellyn Harris","orcid":"https://orcid.org/0000-0003-1376-8409","observed_orcids":["https://orcid.org/0000-0003-1376-8409"]},"institutions":[{"id":"https://openalex.org/I147962203","display_name":"Democritus University of Thrace","ror":"https://ror.org/03bfqnx40","country_code":"GR","type":"education","lineage":["https://openalex.org/I147962203"]},{"id":"https://openalex.org/I150569930","display_name":"Bayer (United States)","ror":"https://ror.org/034ffbg36","country_code":"US","type":"company","lineage":["https://openalex.org/I150569930","https://openalex.org/I67348948"]},{"id":"https://openalex.org/I2801316944","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I2801316944"]},{"id":"https://openalex.org/I2802742124","display_name":"John Radcliffe Hospital","ror":"https://ror.org/0080acb59","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802742124","https://openalex.org/I4210127145","https://openalex.org/I4210147381"]},{"id":"https://openalex.org/I4210143288","display_name":"Bayer (Finland)","ror":"https://ror.org/03cmx5943","country_code":"FI","type":"company","lineage":["https://openalex.org/I4210143288","https://openalex.org/I67348948"]},{"id":"https://openalex.org/I4210162051","display_name":"University Hospital Carl Gustav Carus","ror":"https://ror.org/04za5zm41","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210162051"]},{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE","FI","GB","GR","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Adrian L. Harris","raw_affiliation_strings":["Authors' Affiliations:\u20081Departments of Pathology and Radiotherapy/Oncology, Democritus University of Thrace, Alexandroupolis, Greece; 2Cancer Research UK, Molecular Oncology Laboratories, Weatherall Institute of Molecular Medicine and Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, Oxford, United Kingdom; 3University of Essen, West German Cancer Center, Essen; 4University Hospital Dresden, Dresden, Germany; 5Novartis Pharmaceuticals Co., East Hanover; 6Bayer Healthcare Pharmaceuticals, New Jersey; 7Bayer Schering Pharma Oy, Espoo, Finland; and 8Bayer Healthcare Pharmaceuticals, Berlin, Germany","Bayer Healthcare Pharmaceuticals, Berlin, Germany","Bayer Healthcare Pharmaceuticals, New Jersey","Bayer Schering Pharma Oy, Espoo, Finland","Novartis Pharmaceuticals Co., East Hanover","University Hospital Dresden, Dresden, Germany","University of Essen, West German Cancer Center, Essen"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Departments of Pathology and Radiotherapy/Oncology, Democritus University of Thrace, Alexandroupolis, Greece; 2Cancer Research UK, Molecular Oncology Laboratories, Weatherall Institute of Molecular Medicine and Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, Oxford, United Kingdom; 3University of Essen, West German Cancer Center, Essen; 4University Hospital Dresden, Dresden, Germany; 5Novartis Pharmaceuticals Co., East Hanover; 6Bayer Healthcare Pharmaceuticals, New Jersey; 7Bayer Schering Pharma Oy, Espoo, Finland; and 8Bayer Healthcare Pharmaceuticals, Berlin, Germany","institution_ids":["https://openalex.org/I147962203","https://openalex.org/I2801316944","https://openalex.org/I2802742124"]},{"raw_affiliation_string":"Bayer Healthcare Pharmaceuticals, Berlin, Germany","institution_ids":["https://openalex.org/I67348948"]},{"raw_affiliation_string":"Bayer Healthcare Pharmaceuticals, New Jersey","institution_ids":["https://openalex.org/I150569930"]},{"raw_affiliation_string":"Bayer Schering Pharma Oy, Espoo, Finland","institution_ids":["https://openalex.org/I4210143288"]},{"raw_affiliation_string":"Novartis Pharmaceuticals Co., East Hanover","institution_ids":[]},{"raw_affiliation_string":"University Hospital Dresden, Dresden, Germany","institution_ids":["https://openalex.org/I4210162051"]},{"raw_affiliation_string":"University of Essen, West German Cancer Center, Essen","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":5,"institutions_distinct_count":7,"corresponding_author_ids":["https://openalex.org/A5026228151"],"corresponding_institution_ids":["https://openalex.org/I147962203","https://openalex.org/I150569930","https://openalex.org/I2801316944","https://openalex.org/I2802742124","https://openalex.org/I4210143288","https://openalex.org/I4210162051","https://openalex.org/I67348948"],"apc_list":null,"apc_paid":null,"fwci":6.811,"has_fulltext":false,"cited_by_count":151,"citation_normalized_percentile":{"value":0.97913149,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":96,"max":100},"biblio":{"volume":"17","issue":"14","first_page":"4892","last_page":"4900"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.9082000255584717,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.9082000255584717,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.04839999973773956,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10631","display_name":"Cancer, Hypoxia, and Metabolism","score":0.033399999141693115,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ldh5","display_name":"LDH5","score":0.925000011920929},{"id":"https://openalex.org/keywords/colorectal-cancer","display_name":"colorectal cancer","score":0.9300000071525574},{"id":"https://openalex.org/keywords/vatalanib","display_name":"vatalanib","score":0.9990000128746033},{"id":"https://openalex.org/keywords/ptk787-zk222584","display_name":"PTK787/ZK222584","score":0.9670000076293945},{"id":"https://openalex.org/keywords/anti-angiogenic-therapy","display_name":"anti-angiogenic therapy","score":0.8920000195503235},{"id":"https://openalex.org/keywords/vegfr-tyrosine-kinase-inhibitors","display_name":"VEGFR inhibitors","score":0.8180000185966492},{"id":"https://openalex.org/keywords/serum-lactate-dehydrogenase","display_name":"serum lactate dehydrogenase","score":0.8999999761581421},{"id":"https://openalex.org/keywords/tumor-hypoxia","display_name":"tumor hypoxia","score":0.7620000243186951},{"id":"https://openalex.org/keywords/hypoxia-inducible-factor","display_name":"hypoxia-inducible factor","score":0.8600000143051147},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.6819999814033508},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.890999972820282},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.777999997138977},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9879999756813049},{"id":"https://openalex.org/keywords/tumor-response-prediction","display_name":"tumor response prediction","score":0.515999972820282},{"id":"https://openalex.org/keywords/confirm-trial","display_name":"CONFIRM trial","score":0.6769999861717224}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7893229722976685},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.7642451524734497},{"id":"https://openalex.org/C2777318727","wikidata":"https://www.wikidata.org/wiki/Q409464","display_name":"Lactate dehydrogenase","level":3,"score":0.7470101118087769},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.616692841053009},{"id":"https://openalex.org/C2778260052","wikidata":"https://www.wikidata.org/wiki/Q117636","display_name":"FOLFOX","level":5,"score":0.576248824596405},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5338433980941772},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4970560371875763},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.44885915517807007},{"id":"https://openalex.org/C2780962732","wikidata":"https://www.wikidata.org/wiki/Q422327","display_name":"Oxaliplatin","level":4,"score":0.3115732967853546},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.08962273597717285},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000080864","descriptor_name":"Lactate Dehydrogenase 5","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007527","descriptor_name":"Isoenzymes","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D007527","descriptor_name":"Isoenzymes","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D007770","descriptor_name":"L-Lactate Dehydrogenase","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D007770","descriptor_name":"L-Lactate Dehydrogenase","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010793","descriptor_name":"Phthalazines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015179","descriptor_name":"Colorectal Neoplasms","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D015179","descriptor_name":"Colorectal Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015179","descriptor_name":"Colorectal Neoplasms","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D015972","descriptor_name":"Gene Expression Regulation, Neoplastic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D045022","descriptor_name":"Lactate Dehydrogenases","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D047368","descriptor_name":"Tumor Burden","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D053208","descriptor_name":"Kaplan-Meier Estimate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1158/1078-0432.ccr-10-2918","doi":"https://doi.org/10.1158/1078-0432.ccr-10-2918","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-10-2918","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},{"id":"pmid:21632858","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21632858","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Journal Article"},{"id":"pmh:oai:europepmc.org:2264689","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3145151","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:3145151","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3145151/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Clin Cancer Res","raw_type":"Text"},{"id":"pmh:oai:bibliographie.ub.uni-due.de:ubo_mods_00118572","doi":null,"is_oa":false,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pubmed/21632858","pdf_url":null,"source":{"id":"https://openalex.org/S7407055102","display_name":"Universit\u00e4tsbibliographie, Universit\u00e4t Duisburg-Essen","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"article"}],"best_oa_location":{"id":"pmh:oai:europepmc.org:2264689","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3145151","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"Text"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G5863603907","display_name":null,"funder_award_id":"A6292","funder_id":"https://openalex.org/F4320319985","funder_display_name":"Cancer Research UK"}],"funders":[{"id":"https://openalex.org/F4320319985","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":23,"referenced_works":["https://openalex.org/W1475495210","https://openalex.org/W1543487738","https://openalex.org/W1964015820","https://openalex.org/W1973277573","https://openalex.org/W1991191090","https://openalex.org/W1997971145","https://openalex.org/W2030494099","https://openalex.org/W2043945031","https://openalex.org/W2049584121","https://openalex.org/W2060426598","https://openalex.org/W2094656553","https://openalex.org/W2112759697","https://openalex.org/W2113135799","https://openalex.org/W2122345196","https://openalex.org/W2126275851","https://openalex.org/W2211228914","https://openalex.org/W2232275277","https://openalex.org/W2244100803","https://openalex.org/W2335775292","https://openalex.org/W3011210265","https://openalex.org/W6689360158","https://openalex.org/W6774898526","https://openalex.org/W6816944741"],"related_works":["https://openalex.org/W2211228914","https://openalex.org/W2113135799","https://openalex.org/W1979877809","https://openalex.org/W2556227383","https://openalex.org/W2164654964","https://openalex.org/W2036953241","https://openalex.org/W3025097281","https://openalex.org/W6998649759","https://openalex.org/W2244301376","https://openalex.org/W3004671293"],"abstract_inverted_index":{"PURPOSE:":[0],"The":[1,222],"Colorectal":[2],"Oral":[3],"Novel":[4],"therapy":[5],"For":[6],"the":[7,18,21,49,56,61,72,88,96,99,153,159,205,227,233],"Inhibition":[8],"of":[9,13,20,51,98,115,119,156,161,207,224,229,235],"angiogenesis":[10],"and":[11,75,107,118,131,167,194,212],"Retarding":[12],"Metastases":[14],"(CONFIRM)-randomized":[15],"trials,":[16],"investigating":[17],"role":[19],"VEGF-receptor":[22],"inhibitor":[23],"PTK787/ZK":[24],"222584":[25],"(vatalanib)":[26],"in":[27,37,65,71,87,152,169,188,209,217],"colorectal":[28,210],"cancer":[29,66,211],"(FOLFOX":[30],"4":[31],"\u00b1":[32],"vatalanib),":[33],"showed":[34],"some":[35],"benefit":[36],"patients":[38,69,85],"with":[39,103,124,178],"high":[40,132],"serum":[41,104,125,173],"lactate":[42],"dehydrogenase":[43],"(LDH)":[44],"levels.":[45],"Here,":[46],"we":[47],"investigated":[48],"expression":[50,97,135,231],"LDH5":[52,100,134,143,196],"(encoded":[53],"entirely":[54],"by":[55,60,93],"LDHA":[57],"gene,":[58],"regulated":[59],"hypoxia":[62],"inducible":[63],"factors)":[64],"tissues":[67],"from":[68,83],"recruited":[70,86],"CONFIRM":[73,89],"trials":[74,90],"relationship":[76],"to":[77,146,164,203,220],"response.":[78],"EXPERIMENTAL":[79],"DESIGN:":[80],"Paraffin-embedded":[81],"materials":[82],"179":[84],"were":[91,109,176],"analyzed":[92],"immunohistochemistry":[94],"for":[95,137],"protein.":[101],"Correlations":[102],"LDH,":[105],"response,":[106],"survival":[108,149],"assessed.":[110],"RESULTS:":[111],"A":[112],"significant":[113],"association":[114],"tumor":[116,133],"burden":[117],"poor":[120,138,147],"performance":[121],"status":[122],"(PS)":[123],"LDH":[126,174,193,208,230],"was":[127,144,185],"noted.":[128],"Poor":[129],"PS":[130],"predicted":[136],"response":[139,166,219],"rates.":[140],"High":[141,172],"tissue":[142,195],"related":[145],"progression-free":[148],"(PFS)":[150],"only":[151],"placebo":[154],"group":[155],"patients,":[157],"whereas":[158],"addition":[160,223],"vatalanib":[162,225],"seemed":[163],"improved":[165],"PFS":[168],"this":[170],"subgroup.":[171],"levels":[175,197],"linked":[177],"significantly":[179],"poorer":[180],"overall":[181],"survival,":[182],"which":[183],"however":[184],"not":[186],"sustained":[187],"multivariate":[189],"analysis.":[190],"CONCLUSIONS:":[191],"Serum":[192],"are":[198],"complementary":[199],"features":[200],"that":[201],"help":[202],"characterize":[204],"activity":[206],"have":[213],"a":[214],"potent":[215],"value":[216],"predicting":[218],"chemotherapy.":[221],"diminished":[226],"impact":[228],"on":[232],"prognosis":[234],"patients.":[236]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2083135484","counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":8},{"year":2021,"cited_by_count":14},{"year":2020,"cited_by_count":8},{"year":2019,"cited_by_count":8},{"year":2018,"cited_by_count":10},{"year":2017,"cited_by_count":17},{"year":2016,"cited_by_count":9},{"year":2015,"cited_by_count":13},{"year":2014,"cited_by_count":16},{"year":2013,"cited_by_count":11},{"year":2012,"cited_by_count":15}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
